Comparisons of the Effect of Balloon Dilatation and Reoperation on Benign Gallbladder Anastomosis
-
摘要:
目的 比较球囊扩张与再次手术治疗良性胆肠吻合口狭窄的疗效。 方法 回顾性分析昆明医科大学第二附属医院2009年2月至2019年6月因良性胆肠吻合口狭窄入院治疗的患者41例,其中球囊扩张治疗组18例,再次手术组23例,对比分析两组治疗所需时间、治疗效果及相关并发症。 结果 球囊扩张治疗组与再次手术治疗组相比,治疗所需时间短、治疗相关并发症少,有统计学意义(P < 0.05);治愈率、复发率和术后胆管炎两组间无统计学意义(P > 0.05);但球囊扩张治疗组治愈率稍偏高。 结论 球囊扩张术在良性胆肠吻合口狭窄治疗中有较高的治愈率,并发症少,是良性胆肠吻合口狭窄安全、有效、可靠的治疗措施。 Abstract:Objective To compare the effects of balloon dilatation and reoperation on benign biliary-enteric anastomotic stenosis. Methods From February 2009 to June 2019, 41 patients with benign biliary and intestinal anastomotic stenosis treated in the Second Affiliated Hospital of Kunming Medical University were retrospectively analyzed, including 18 cases in the balloon dilatation treatment group and 23 cases in the reoperation group. And the treatment time, treatment effect and related complications in the two groups were compared. Results Compared with the re-operation group, the balloon dilatation treatment group had the shorter treatment time and fewer treatment-related complications (P < 0.05) and there was no significant difference in cure rate, recurrence rate and postoperative cholangitis between the two groups (P > 0.05) but the cure rate of balloon dilation treatment group was slightly higher.. Conclusion Balloon dilatation has a higher cure rate and fewer complications in the treatment of benign biliary-enteric anastomotic stenosis, and it is a safe, effective, and reliable treatment for benign biliary-enteric anastomotic stenosis. -
Key words:
- Benign bilioenteric strictures /
- Reoperation /
- Balloon dilation
-
表 1 球囊扩张治疗组与再次手术治疗组一般资料比较(
$\bar x\pm s $ )Table 1. Comparison of general data between balloon dilatation treatment group and reoperation treatment group(
$ \bar x\pm s$ )项目 球囊扩张治疗组(n = 18) 再次手术治疗组(n = 23) χ2/t P 性别(男/女) 8/10 10/13 0.004 0.951 年龄(岁) 47.7 ± 13.5 48.5 ± 12.9 −0.523 0.604 表 2 球囊扩张治疗组与再次手术治疗组疗效比较(
$\bar x \pm s$ )Table 2. Comparison of curative effect between balloon dilatation treatment group and reoperation treatment group(
$\bar x \pm s$ )分组 治疗时间(min) 治愈(n) 狭窄复发(n) 术后胆管炎 治疗相关并发症(n) 球囊扩张治疗组 68.3 ± 22.9# 17 1 2 3# 再次手术治疗组 175.6 ± 57.5 20 3 3 11 χ2/t −9.486 0.074 0.074 0.000 4.36 P 0.000 0.786 0.786 0.995 0.037 与再次手术治疗组比较,#P < 0.05。 -
[1] Zhu Ji-Qiao, Li Xian-Liang, Kou Jian-Tao, et al. Bilioenteric anastomotic stricture in patients with benign and malignant tumors: prevalence, risk factors and treatment[J]. HBPD INT,2017,16(4):412-417. [2] 张诚,杨玉龙,吴萍,等. 全覆膜自膨式可回收金属支架治疗胆肠吻合术后复发性吻合口狭窄[J].中华外科杂志,2014,52(4):306-307. doi: 10.3760/cma.j.issn.0529-5815.2014.04.017 [3] Jang Sung Ill,Rhee Kwangwon,Kim Haewon,et al. Recanalization of refractory benign biliary stricture using magnetic compression anastomosis[J]. Endoscopy,2014,46(1):70-74. [4] House Michael G, Cameron John L, Schulick Richard D, et al. Incidence and outcome of biliary strictures after pancreaticoduodenectomy[J]. Ann Surg,2006,243(5):571-576. [5] Johnson S R, Koehler A, Pennington L K, et al. Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy[J]. Surgery,2000,128(4):668-677. [6] Moraca Robert J, Lee Faye T, Ryan John A, et al. Long-term biliary function after reconstruction of major bile duct injuries with hepaticoduodenostomy or hepaticojejunostomy[J]. Arch Surg,2002,137(8):889-893. doi: 10.1001/archsurg.137.8.889 [7] Murr M M, Gigot J F, Nagorney D M, et al. Long-term results of biliary reconstruction after laparoscopic bile duct injuries[J]. Arch Surg,1999,134(6):604-609. [8] Sicklick Jason K, Camp Melissa S, Lillemoe Keith D, et al. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients[J]. Ann Surg,2005,241(5):786-792. [9] 张诚, 杨玉龙, 史力军, 等. 胆道镜下高频电切治疗胆肠吻合术后吻合口狭窄[J].中华普通外科杂志,2015,30(7):529-531. doi: 10.3760/cma.j.issn.1007-631X.2015.07.008 [10] Vellar I D. The blood supply of the biliary ductal system and its relevance to vasculobiliary injuries following cholecystectomy[J]. Aust N Z J Surg,1999,69(11):816-820. [11] 苏茂生. 良性胆管狭窄及肝移植术后胆道并发症的临床研究[D]. 北京: 中国人民解放军军医进修学院(博士学位论文), 2007. [12] 邓世康. 胆管瘢痕差异蛋白研究及Activin B在UDCA治疗瘢痕中作用的研究[D]. 昆明: 昆明医科大学(博士学位论文), 2015. [13] 袁珺. 低浓度胆盐对人正常胆管成纤维细胞的生物学影响[D]. 昆明: 昆明医科大学(硕士学位论文), 2014. [14] Tocchi A, Mazzoni G, Liotta G, et al. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: A follow-up study of more than 1,000 patients[J]. Ann Surg,2001,234(2):210-214. [15] 窦科峰, 杨雁灵. 胆道再次手术(胆肠吻合)的指征及术式选择[J].中国实用外科杂志,2006,26(3):232-233. doi: 10.3321/j.issn:1005-2208.2006.03.033 [16] 张诚, 杨玉龙, 吴萍, 等. 持续性球囊扩张治疗胆肠吻合术后复发性吻合口狭窄[J].中国普外基础与临床杂志,2015,22(10):1251-1253. doi: 10.7507/1007-9424.20150324 [17] 华成飞, 李腾飞, 段旭华, 等. 渐进性球囊扩张联合胆道持续引流治疗胆肠吻合术后吻合口良性狭窄[J].介入放射学杂志,2017,26(4):339-343. doi: 10.3969/j.issn.1008-794X.2017.04.013 [18] 程龙, 白旭明, 顾星石, 等. 胆肠吻合口良性狭窄的切割球囊治疗[J].中华普通外科杂志,2013,28(11):833-835. doi: 10.3760/cma.j.issn.1007-631X.2013.11.006 [19] 徐佳, 冯秋实. 纤维胆道镜治疗胆肠吻合术后吻合口狭窄30例[J].中国内镜杂志,2013,19(7):714-716. [20] Bonnel Didier H, Fingerhut Abe L. Percutaneous transhepatic balloon dilatation of benign bilioenteric strictures: long-term results in 110 patients[J]. Am J Surg,2012,203(6):675-683. doi: 10.1016/j.amjsurg.2012.02.001 [21] Lee Andrew Y, Gregorius John, Kerlan Robert K, et al. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries[J]. PLoS ONE,2012,7(10):1-5. 期刊类型引用(21)
1. 林洪盛,刘利敏,鲁秋香,吴清. 新辅助化疗对非小细胞肺癌患者肿瘤标志物与细胞凋亡相关因子的影响. 中国医学创新. 2023(03): 45-49 . 百度学术
2. 何佳,白美玲. 吉非替尼靶向治疗非小细胞肺癌对患者血清CA125、CEA、NSE水平及不良反应的影响. 当代医学. 2021(18): 167-168 . 百度学术
3. 何显阳,刘方文,黄云英,赖红宇,王志春. 多西他赛联合顺铂新辅助化疗对非小细胞肺癌治疗中相关肿瘤标记物的影响. 医学信息. 2021(23): 165-167 . 百度学术
4. 吴皓,李萍. 奥希替尼联合放化疗治疗晚期非小细胞肺癌患者的临床疗效及安全性分析. 中国肿瘤临床与康复. 2020(04): 400-403 . 百度学术
5. 雒润华. 健脾化痰逐淤方结合靶向药物治疗晚期EGFR突变阳性肺腺癌. 深圳中西医结合杂志. 2020(14): 45-46 . 百度学术
6. 章伟. 吉非替尼靶向治疗对非小细胞肺癌患者血清CA125 CEA NSE水平的影响. 基层医学论坛. 2020(26): 3846-3847 . 百度学术
7. 曹参,李靖,吴勤研. 吉非替尼联合化疗方案应用于晚期肺腺癌患者的临床疗效及安全性分析. 中华肺部疾病杂志(电子版). 2020(04): 484-487 . 百度学术
8. 姚丽鸽,王留晏,周寒丽,段方方,陈露,张克克. 沙利度胺联合GP方案化疗对晚期非小细胞肺癌患者生存时间和生存质量的影响. 癌症进展. 2019(12): 1400-1403 . 百度学术
9. 张治业. 沙利度胺联合TP方案化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响. 淮海医药. 2019(04): 338-340 . 百度学术
10. 廖丽军,李鹏辉. 新辅助化疗治疗Ⅲ期非小细胞肺癌的临床疗效观察. 中国现代医生. 2019(19): 102-104 . 百度学术
11. 文慧,彭彦才,艾葆春,郝光军,李小峰. 阿帕替尼联合紫杉醇对非小细胞肺癌患者的疗效及血清因子的影响. 药物评价研究. 2019(09): 1810-1813 . 百度学术
12. 莫遗盛,周伯庭,毛艳,王冬梅. 沙利度胺治疗实体瘤的研究进展. 微创医学. 2018(03): 344-347 . 百度学术
13. 惠广盈,刘楠. 手术前后联合化疗对非小细胞肺癌患者生存质量及不良反应的影响. 西北国防医学杂志. 2018(01): 35-38 . 百度学术
14. 顾晶晶. 吉非替尼联合沙利度胺治疗非小细胞肺癌的临床疗效分析. 中国现代应用药学. 2018(07): 1073-1076 . 百度学术
15. 梁华,李彦磊,高炜. 吉非替尼联合化疗治疗原发性ⅢB、Ⅳ期非小细胞肺癌的临床研究. 中国医学前沿杂志(电子版). 2018(03): 58-61 . 百度学术
16. 王宏,夏永寿,加静,张燕,王瑛. 沙利度胺联合吉非替尼靶向治疗非小细胞肺癌的临床效果观察. 现代生物医学进展. 2018(23): 4474-4477 . 百度学术
17. 武乐,叶华姝,刘震天. 吉非替尼与沙利度胺联用对非小细胞肺癌患者的临床疗效及其对CEA和CA125水平的影响. 抗感染药学. 2018(12): 2118-2121 . 百度学术
18. 杨建刚,陈继正,赵参军,王昕洁,钱仲,郑瑾. 沙利度胺在治疗晚期实体肿瘤中的应用及研究进展. 现代肿瘤医学. 2017(11): 1805-1809 . 百度学术
19. 玛依拉·阿不都克力木,库尔班江·吐尔逊. 沙利度胺联合吉非替尼新辅助化疗对非小细胞肺癌患者的疗效与安全性分析. 实用癌症杂志. 2017(04): 582-585 . 百度学术
20. 龚玉芳,刘峰,杨志胤,姜斌. 新辅助化疗前后非小细胞肺癌患者血清CA125、CEA及CYFRA21-1的变化及预后分析. 中国医药导报. 2017(11): 91-94 . 百度学术
21. 胡洪林. 吉非替尼联合简化调强放疗技术治疗非小细胞肺癌临床研究. 中国药业. 2017(09): 38-40 . 百度学术
其他类型引用(1)
-